Alector Inc (ALEC)
3.94
+0.18
(+4.79%)
USD |
NASDAQ |
Nov 22, 16:00
3.95
+0.01
(+0.25%)
After-Hours: 20:00
Alector Revenue (Annual): 97.06M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 97.06M |
| December 31, 2022 | 133.62M |
| December 31, 2021 | 207.08M |
| December 31, 2020 | 21.10M |
| Date | Value |
|---|---|
| December 31, 2019 | 21.22M |
| December 31, 2018 | 27.68M |
| December 31, 2017 | 3.735M |
| December 31, 2016 | 0.416M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
21.10M
Minimum
2020
207.08M
Maximum
2021
96.02M
Average
97.06M
Median
2023
Revenue (Annual) Benchmarks
| Precision BioSciences Inc | 48.73M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.490M |
| iBio Inc | 0.225M |
| Theriva Biologics Inc | -- |